LALPATHLAB Volatility

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>DL</div>
LALPATHLAB -- India Stock  

INR 1,618  46.85  2.98%

DR LAL appears to be very steady, given 3 months investment horizon. DR LAL PATHLABS retains Efficiency (Sharpe Ratio) of 0.11, which denotes the company had 0.11% of return per unit of price deviation over the last 3 months. Our outlook to predicting the volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for DR LAL, which you can use to evaluate future volatility of the firm. Please utilize DR LAL PATHLABS standard deviation of 2.65, downside deviation of 2.85, and market risk adjusted performance of 0.3955 to check if our risk estimates are consistent with your expectations.

Search Volatility

 
Refresh
DR LAL Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of LALPATHLAB daily returns, and it is calculated using variance and standard deviation. We also use LALPATHLAB's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of DR LAL volatility.

90 Days Market Risk

Very steady

Chance of Distress

Below Average

90 Days Economic Sensitivity

Slowly supersedes the market

DR LAL Market Sensitivity And Downside Risk

DR LAL PATHLABS beta coefficient measures the volatility of LALPATHLAB stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents LALPATHLAB stock's returns against your selected market. In other words, DR LAL's beta of 0.43 provides an investor with an approximation of how much risk DR LAL stock can potentially add to one of your existing portfolios. Let's try to break down what LALPATHLAB's beta means in this case. As returns on the market increase, DR LAL returns are expected to increase less than the market. However, during the bear market, the loss on holding DR LAL will be expected to be smaller as well.
3 Months Beta |Analyze DR LAL PATHLABS Demand Trend
Check current 30 days DR LAL correlation with market (DOW)
β

Current DR LAL Beta Coefficient

 = 

DR LAL Central Daily Price Deviations

It is essential to understand the difference between upside risk (as represented by DR LAL's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of DR LAL stock's daily returns or price. Since the actual investment returns on holding a position in DR LAL stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in DR LAL.

DR LAL PATHLABS Volatility Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. DR LAL PATHLABS Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

DR LAL Projected Return Density Against Market

Assuming the 30 trading days horizon, DR LAL has a beta of 0.434 . This indicates as returns on the market go up, DR LAL average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding DR LAL PATHLABS will be expected to be much smaller as well. Moreover, Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to DR LAL or DR LAL PATHLABS sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that DR LAL stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a LALPATHLAB stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. The company has an alpha of 0.0538, implying that it can generate a 0.0538 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Predicted Return Density 
      Returns 

DR LAL Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to DR LAL or DR LAL PATHLABS sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that DR LAL stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a LALPATHLAB stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Assuming the 30 trading days horizon, the coefficient of variation of DR LAL is 936.57. The daily returns are destributed with a variance of 3.73 and standard deviation of 1.93. The mean deviation of DR LAL PATHLABS is currently at 1.35. For similar time horizon, the selected benchmark (DOW) has volatility of 2.14
α
Alpha over DOW
=0.05
β
Beta against DOW=0.43
σ
Overall volatility
=1.93
Ir
Information ratio =-0.04

DR LAL Return Volatility

DR LAL historical daily return volatility represents how much DR LAL stock's price daily returns swing around its mean daily price change - it is a statistical measure of its dispersion of returns. The company accepts 1.9322% volatility on return distribution over the 30 days horizon. By contrast, DOW inherits 1.8606% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

About DR LAL Volatility

Volatility is a rate at which the price of DR LAL or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of DR LAL may increase or decrease. In other words, similar to LALPATHLAB's beta indicator, it measures the risk of DR LAL and helps estimate the fluctuations that may happen in a short period of time. So if prices of DR LAL fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility. Please read more on our technical analysis page.
Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India. DR LAL operates under Diagnostics Research classification in India and is traded on National Stock Exchange of India.

DR LAL Investment Opportunity

DR LAL PATHLABS has a volatility of 1.93 and is 1.04 times more volatile than DOW. 16  of all equities and portfolios are less risky than DR LAL. Compared to the overall equity markets, volatility of historical daily returns of DR LAL PATHLABS is lower than 16 () of all global equities and portfolios over the last 30 days. Use DR LAL PATHLABS to enhance returns of your portfolios. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of DR LAL to be traded at 1941.3 in 30 days. . Let's try to break down what LALPATHLAB's beta means in this case. As returns on the market increase, DR LAL returns are expected to increase less than the market. However, during the bear market, the loss on holding DR LAL will be expected to be smaller as well.

DR LAL correlation with market

correlation synergy
Weak diversification
Overlapping area represents the amount of risk that can be diversified away by holding DR LAL PATHLABS LT and equity matching DJI index in the same portfolio.

DR LAL Additional Risk Indicators

The analysis of various secondary risk indicators of DR LAL is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in DR LAL investment, and either accepting that risk or mitigating it. Along with some common measures of DR LAL stock risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging your existing portfolio. Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing the like to determine which investment holds the most risk.
Risk Adjusted Performance0.1447
Market Risk Adjusted Performance0.3955
Mean Deviation1.83
Semi Deviation2.42
Downside Deviation2.85
Coefficient Of Variation1496.75
Standard Deviation2.65

DR LAL Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
Ford vs. DR LAL
Ameri Holdings vs. DR LAL
Facebook vs. DR LAL
Zendesk vs. DR LAL
Qualigen Therapeutics vs. DR LAL
Microsoft vs. DR LAL
GM vs. DR LAL
National Savings vs. DR LAL
Sprint vs. DR LAL
Salesforce vs. DR LAL
Additionally, see Stocks Correlation. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page